• By ICR Secretariat
  • Posted Wednesday, January 13, 2021

Tocilizumab and sarilumab cut risk of death in severe COVID-19 patients

http://www.pharmatimes.com/news/tocilizumab_and_sarilumab_cut_risk_of_death_in_severe_covid-19_patients_1360960

Two anti-inflammatory drugs, used to treat a range of conditions including arthritis, have found to reduce the risk of death in severe COVID-19 cases.